Creative Capital Management Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
645
+16
+3% +$5.48K 0.05% 78
2026
Q1
$221K Hold
629
0.06% 50
2025
Q4
$206K Hold
629
0.06% 52
2025
Q3
$178K Hold
629
0.06% 58
2025
Q2
$176K Sell
629
-20
-3% -$5.67K 0.06% 58
2025
Q1
$202K Hold
649
0.08% 47
2024
Q4
$169K Hold
649
0.07% 55
2024
Q3
$209K Buy
649
+637
+5,308% +$208K 0.09% 46
2024
Q2
$3.75K Sell
12
-17
-59% -$4.99K ﹤0.01% 196
2024
Q1
$8.24K Hold
29
﹤0.01% 163
2023
Q4
$8.35K Hold
29
﹤0.01% 159
2023
Q3
$7.79K Buy
+29
New +$7.24K 0.01% 165

Other funds holding AMGN

Creative Capital Management Investments's AMGN Position: Q2 2026 in Review

Creative Capital Management Investments increased its Amgen (AMGN) stake by 2.5% in Q2 2026, buying an estimated $5.48K and bringing the position to 645 shares worth $234K. The position accounts for 0.05% of the portfolio, ranked #78.

Creative Capital Management Investments first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Creative Capital Management Investments held 645 shares of Amgen worth $234K as of Q2 2026.
  • Creative Capital Management Investments bought 16 Amgen shares in Q2 2026, an estimated $5.48K.
  • Amgen made up 0.05% of Creative Capital Management Investments's portfolio in Q2 2026, its #78 holding.
  • Creative Capital Management Investments first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.